
  
    
      
        Background_NNP
        Although_IN intense_JJ efforts_NNS are_VBP being_VBG directed_VBN toward_IN the_DT
        development_NN of_IN safe_JJ and_CC effective_JJ viral_JJ vectors_NNS that_WDT permit_VBP
        the_DT introduction_NN of_IN foreign_JJ genes_NNS into_IN mammalian_JJ cells_NNS ,_,
        chemical_NN transfection_NN continues_VBZ to_TO attract_VB interest_NN ,_, not_RB
        only_RB because_IN chemicals_NNS are_VBP less_RBR difficult_JJ to_TO use_VB from_IN a_DT
        technical_JJ standpoint_NN ,_, but_CC also_RB because_IN this_DT form_NN of_IN gene_NN
        transfer_NN may_MD prove_VB less_RBR toxic_JJ and_CC immunogenic_JJ from_IN a_DT
        therapeutic_JJ perspective_NN [_NN 1_CD ]_NN ._. Synthetic_NNP vectors_NNS include_VBP
        cationic_JJ polymers_NNS such_JJ as_IN polyethyleneimine_NN (_( PEI_NNP )_) and_CC
        polylysine_NN ,_, as_RB well_RB as_IN cationic_JJ lipids_NNS such_JJ as_IN
        Lipofectamine_NNP [_NN 2_CD ]_NN and_CC negatively_RB charged_VBN liposomes_NNS [_NN 3_CD ]_NN ._.
        The_DT unique_JJ chemical_NN properties_NNS of_IN PEI_NNP underscore_VBP its_PRP$
        potential_JJ as_IN a_DT vector_NN for_IN gene_NN delivery_NN ._. For_IN example_NN ,_, PEI_NNP
        has_VBZ a_DT very_RB high_JJ cationic_JJ charge_NN density_NN ,_, making_VBG it_PRP useful_JJ
        for_IN binding_JJ anionic_JJ DNA_NNP within_IN the_DT physiological_JJ pH_NN range_NN [_NN
        4_CD ]_NN and_CC forcing_VBG the_DT DNA_NNP to_TO form_VB condensates_NNS small_JJ enough_RB to_TO
        be_VB effectively_RB endocytosed_JJ [_NN 5_CD ]_NN ,_, which_WDT is_VBZ the_DT primary_JJ mode_NN
        of_IN the_DT PEI_NNP /_NN DNA_NNP complex_JJ into_IN the_DT cell_NN [_NN 1_CD ,_, 6_CD ,_, 7_CD ]_NN ._. Via_NNP the_DT
        endosomal_NN compartment_NN ,_, PEI_NNP /_NN DNA_NNP complexes_NNS travel_VBP to_TO the_DT
        nucleus_NN ,_, whereupon_NN the_DT plasmid_NN DNA_NNP is_VBZ expressed_VBN within_IN 5_CD
        hours_NNS after_IN the_DT initial_JJ attachment_NN of_IN the_DT complexes_NNS to_TO the_DT
        cell_NN surface_NN [_NN 7_CD ]_NN ._. Another_DT property_NN of_IN PEI_NNP that_WDT makes_VBZ it_PRP
        suitable_JJ as_IN a_DT DNA_NNP vector_NN is_VBZ its_PRP$ structure_NN ,_, in_IN which_WDT every_DT
        third_JJ atom_NN is_VBZ a_DT protonatable_JJ amino_JJ nitrogen_NN that_WDT allows_VBZ the_DT
        polymer_NN to_TO function_VB as_IN an_DT effective_JJ buffering_VBG system_NN for_IN
        the_DT sudden_JJ decrease_NN in_IN pH_NN from_IN the_DT extracellular_NN
        environment_NN to_TO the_DT endosomal_NN /_NN lysosomal_NN compartment_NN ._. This_DT
        feature_NN is_VBZ important_JJ for_IN the_DT protection_NN of_IN genetic_JJ material_NN
        as_IN it_PRP travels_VBZ to_TO the_DT nucleus_NN [_NN 4_CD ,_, 7_CD ]_NN ._.
        Over_IN 30_CD cell_NN lines_NNS have_VBP been_VBN successfully_RB transfected_JJ
        using_VBG PEI_NNP ,_, including_VBG COS-_NNP 7_CD cells_NNS [_NN 8_CD ]_NN ,_, rat_NN hepatocytes_NNS [_NN
        3_CD ]_NN ,_, human_JJ dendritic_JJ cells_NNS [_NN 9_CD ,_, 10_CD ]_NN ,_, and_CC mouse_NN mammary_JJ
        epithelial_NN cells_NNS [_NN 11_CD ]_NN ._. Especially_RB exciting_JJ is_VBZ the_DT ability_NN
        of_IN PEI_NNP to_TO introduce_VB foreign_JJ genetic_JJ material_NN into_IN fully_RB
        differentiated_JJ ,_, postmitotic_JJ cells_NNS 
        in_IN vitro_NN ._. Such_JJ examples_NNS include_VBP
        mouse_NN myotubes_NNS [_NN 2_CD ]_NN and_CC chick_NN embryonic_JJ neurons_NNS [_NN 4_CD ]_NN ._.
        Lambert_NNP et_CC al_NN ._. [_NN 12_CD ]_NN also_RB demonstrated_VBD PEI-mediated_NNP uptake_NN
        of_IN nucleic_JJ acids_NNS in_IN rat_NN sympathetic_JJ neuronal_NN /_NN glial_NN
        cocultures_NNS in_IN serum-supplemented_JJ media_NNS ._. In_IN this_DT report_NN ,_, we_PRP
        describe_VBP the_DT application_NN of_IN PEI_NNP in_IN the_DT transfection_NN of_IN
        postmitotic_JJ rat_NN sympathetic_JJ neurons_NNS in_IN serum-free_JJ ,_,
        glia-free_JJ conditions_NNS ,_, thereby_RB showing_VBG the_DT capability_NN of_IN PEI_NNP
        as_IN a_DT method_NN for_IN studying_VBG the_DT effects_NNS of_IN targeted_VBN genetic_JJ
        manipulation_NN in_IN a_DT rigorously_RB defined_VBN cell_NN culture_NN system_NN ._.
        In_IN addition_NN ,_, we_PRP show_VBP that_IN foreign_JJ genetic_JJ material_NN can_MD also_RB
        be_VB introduced_VBN into_IN human_JJ retinal_JJ neurons_NNS that_WDT are_VBP decades_NNS
        old_JJ ._.
      
      
        Results_NNS
        
          Expression_NNP of_IN β-galactosidase_JJ in_IN SCG_NNP neurons_NNS
          Transfection_NNP conditions_NNS were_VBD optimized_JJ using_VBG cultures_NNS
          of_IN postmitotic_JJ sympathetic_JJ neurons_NNS that_WDT had_VBD been_VBN treated_VBN
          with_IN a_DT DNA_NNP synthesis_NN inhibitor_NN to_TO remove_VB nonneuronal_NN
          cells_NNS ._. Neurons_NNP were_VBD transfected_JJ on_IN the_DT fifth_JJ day_NN 
          in_IN vitro_NN ._.
          Three_CD days_NNS after_IN transfection_NN ,_, β-galactosidase_JJ (_( β-gal_JJ )_)
          activity_NN was_VBD detected_VBN in_IN a_DT subpopulation_NN of_IN sympathetic_JJ
          neurons_NNS (_( Figure_NN 1_CD Aand_NNP 1_CD B_NNP )_) ._. Labeling_VBG was_VBD present_JJ in_IN both_DT
          the_DT soma_NN and_CC processes_NNS ._. Labeled_NNP axons_NNS could_MD be_VB followed_VBN
          for_IN many_JJ millimeters_NNS ,_, and_CC growth_NN cones_NNS were_VBD consistently_RB
          labeled_VBN ._. β-gal_JJ protein_NN could_MD also_RB be_VB detected_VBN using_VBG
          immunocytochemical_JJ methods_NNS ,_, and_CC the_DT labeling_VBG pattern_NN was_VBD
          identical_JJ to_TO that_DT detected_VBD using_VBG X-_NNP gal_NN (_( Figure_NN 1_CD C_NNP )_) ._.
          Another_DT gene_NN that_WDT is_VBZ commonly_RB used_VBN to_TO identify_VB
          transfected_JJ cells_NNS ,_, EGFP_NNP ,_, was_VBD also_RB successfully_RB introduced_VBN
          into_IN sympathetic_JJ neurons_NNS using_VBG PEI_NNP (_( Figure_NN 1_CD D_NNP )_) ._. As_IN with_IN
          β-gal_JJ ,_, EGFP_NNP was_VBD detected_VBN throughout_IN the_DT neurons_NNS ,_,
          including_VBG synaptic_JJ varicosities_NNS and_CC growth_NN cones_NNS ._.
          Pretreatment_NNP of_IN our_PRP$ cultures_NNS with_IN
          cytosine-_NN D-_NNP arabinofuranoside_NN prior_RB to_TO transfection_NN almost_RB
          completely_RB eliminates_VBZ the_DT presence_NN of_IN nonneuronal_NN cells_NNS [_NN
          13_CD ]_NN ._. To_TO further_VB demonstrate_VB that_IN the_DT transfected_JJ cells_NNS in_IN
          our_PRP$ cultures_NNS are_VBP neurons_NNS ,_, we_PRP transfected_JJ cultures_NNS with_IN
          the_DT plasmid_NN encoding_VBG EGFP_NNP ,_, and_CC then_RB immunostained_JJ them_PRP
          using_VBG an_DT antibody_NN for_IN microtubule-associated_JJ protein_NN 2_CD
          (_( MAP_NNP 2_LS )_) ,_, a_DT neuron-specific_JJ marker_NN ._. Ninety-five_NNP out_IN of_IN 100_CD
          EGFP_NNP +_NN cells_NNS were_VBD also_RB MAP_NNP 2_CD +_NN (_( Figure_NN 2_LS )_) ,_, indicating_VBG that_IN
          the_DT vast_JJ majority_NN of_IN transfected_JJ cells_NNS in_IN our_PRP$ cultures_NNS
          are_VBP neurons_NNS ._. Those_DT few_JJ cells_NNS that_WDT expressed_VBD EGFP_NNP but_CC not_RB
          MAP_NNP 2_CD possessed_VBD a_DT clearly_RB distinct_JJ morphology_NN from_IN the_DT
          neurons_NNS ,_, such_JJ as_IN smaller_JJR size_NN and_CC shorter_JJR processes_VBZ ,_, and_CC
          thus_RB were_VBD easily_RB distinguished_VBN from_IN neurons_NNS in_IN subsequent_JJ
          experiments_NNS ._.
        
        
          Transfection_NNP efficiency_NN is_VBZ dependent_JJ on_IN DNA_NNP :_: PEI_NNP
          ratio_NN and_CC concentration_NN
          Consistent_NNP with_IN previous_JJ results_NNS [_NN 4_CD ,_, 8_CD ,_, 9_CD ,_, 15_CD ,_, 16_CD ,_, ]_NN ,_,
          we_PRP found_VBD that_IN the_DT β-gal_JJ transfection_NN efficiency_NN varied_VBD
          according_VBG to_TO the_DT ratio_NN of_IN DNA_NNP to_TO PEI_NNP (_( Figure_NN 3_LS )_) ._. Peak_NNP
          yield_VB was_VBD observed_VBN at_IN a_DT ratio_NN of_IN 1_CD μg_NN plasmid_NN DNA_NNP to_TO 5_CD μg_NN
          PEI_NNP (_( concentration_NN of_IN PEI_NNP stock_NN is_VBZ 1_CD μg_NN /_NN μl_NN )_) in_IN 1_CD ml_NN
          culture_NN media_NNS ,_, producing_VBG ∼_NN 9_CD %_NN transfected_JJ cells_NNS ._. As_IN the_DT
          number_NN of_IN protonatable_JJ nitrogens_NNS on_IN the_DT linear_JJ 22_CD kD_NN
          ExGen_NNP 500_CD PEI_NNP polymer_NN at_IN physiological_JJ pH_NN is_VBZ roughly_RB
          equal_JJ to_TO 5_CD ._. 47_CD nmol_NN per_IN μg_NN PEI_NNP ,_, and_CC 1_CD μg_NN DNA_NNP corresponds_NNS
          to_TO 3_CD nmol_NN phosphate_NN groups_NNS ,_, this_DT means_VBZ that_IN the_DT peak_NN
          yield_NN observed_VBD was_VBD at_IN a_DT PEI_NNP nitrogen_NN :_: DNA_NNP phosphate_NN (_( N_NNP /_NN P_NN )_)
          ratio_NN of_IN ∼_NN 9_CD ._. Thus_RB ,_, the_DT most_RBS suitable_JJ N_NNP /_NN P_NN ratio_NN for_IN 
          in_IN vitro_NN sympathetic_JJ neurons_NNS
          appears_VBZ to_TO be_VB around_IN 9_CD ,_, creating_VBG positively_RB charged_VBN
          DNA_NNP /_NN PEI_NNP complexes_NNS [_NN 17_CD ]_NN ._.
          The_DT percentage_NN of_IN β-gal_JJ +_NN neurons_NNS varied_VBD according_VBG to_TO
          the_DT total_JJ amount_NN of_IN DNA_NNP /_NN PEI_NNP complex_NN added_VBD to_TO the_DT
          cultures_NNS ._. Keeping_VBG the_DT 1_CD :_: 5_CD DNA_NNP :_: PEI_NNP ratio_NN constant_JJ ,_, lower_JJR
          yields_NNS were_VBD obtained_VBN at_IN 0_CD ._. 2_CD :_: 1_CD and_CC 0_CD ._. 5_CD :_: 2_CD ._. 5_CD DNA_NNP :_: PEI_NNP
          (_( Figure_NN 4_LS )_) ._. Toxicity_NNP increased_VBD at_IN higher_JJR overall_JJ amounts_NNS
          of_IN DNA_NNP /_NN PEI_NNP (_( Figure_NN 5_LS )_) ._.
        
        
          Kinetics_NNP of_IN foreign_JJ gene_NN expression_NN
          Sympathetic_NNP neurons_NNS were_VBD transfected_JJ with_IN β-gal_JJ
          plasmid_NN and_CC PEI_NNP (_( 1_CD μg_NN :_: 5_CD μg_NN ratio_NN )_) ._. At_IN various_JJ times_NNS
          thereafter_RB (_( 6_CD h_NN ,_, 1_CD d_SYM ,_, 3_CD d_SYM ,_, 5_CD d_SYM ,_, 10_CD d_SYM ,_, 21_CD d_SYM )_) ,_, cells_NNS were_VBD
          fixed_VBN and_CC assayed_JJ for_IN the_DT presence_NN of_IN β-galactosidase_JJ
          activity_NN ._. β-gal_JJ +_NN neurons_NNS were_VBD detected_VBN as_RB soon_RB as_IN 6_CD h_NN
          post-transfection_JJ (_( Figure_NN 6_CD )_) ,_, a_DT finding_VBG consistent_JJ with_IN
          previous_JJ work_NN [_NN 7_CD ]_NN ._. A_DT maximum_NN of_IN ∼_NN 9_CD %_NN β-gal_JJ +_NN neurons_NNS were_VBD
          observed_VBN at_IN 3_CD d_SYM post-transfection_JJ with_IN 1_CD :_: 5_CD DNA_NNP :_: PEI_NNP ,_,
          followed_VBN by_IN a_DT progressive_JJ decrease_NN from_IN 3_CD d_SYM to_TO 10_CD d_SYM ._.
          During_IN this_DT time_NN ,_, many_JJ β-gal_JJ +_NN neurons_NNS appeared_VBD to_TO either_CC
          die_VB or_CC cease_VB expression_NN of_IN the_DT foreign_JJ gene_NN ._. However_RB ,_, the_DT
          percent_NN of_IN cells_NNS expressing_VBG β-galactosidase_JJ at_IN 10_CD d_SYM
          (_( 4_CD ._. 8_CD %_NN )_) was_VBD similar_JJ to_TO the_DT percent_NN at_IN 21_CD d_SYM (_( 4_CD ._. 7_CD %_NN )_) ._. This_DT
          suggests_VBZ that_IN the_DT neurons_NNS that_WDT still_RB expressed_VBD
          β-galactosidase_JJ by_IN 10_CD d_SYM continued_VBD to_TO do_VB sothrough_NN 21_CD d_SYM ._.
          Therefore_RB ,_, PEI-mediated_NNP β-gal_JJ expression_NN in_IN a_DT certain_JJ
          percent_NN of_IN neurons_NNS is_VBZ persistent_JJ ._.
        
        
          Co-transfection_NNP of_IN β-gal_JJ ,_, EGFP_NNP
          To_TO determine_VB how_WRB efficiently_RB co-transfection_JJ occurred_VBD
          with_IN PEI_NNP ,_, we_PRP used_VBD β-gal_JJ and_CC EGFP_NNP together_RB in_IN a_DT 1_CD :_: 1_CD
          ratio_NN ,_, with_IN the_DT overall_JJ DNA_NNP :_: PEI_NNP ratio_NN at_IN 2_CD μg_NN plasmid_NN
          DNA_NNP :_: 5_CD μg_NN PEI_NNP /_NN ml_NN culture_NN media_NNS ._. Neurons_NNP expressing_VBG EGFP_NNP
          were_VBD also_RB found_VBN to_TO express_VB β-galactosidase_JJ (_( Figure_NN 7_CD )_) ._. 23_CD
          out_IN of_IN 24_CD transfected_JJ neurons_NNS examined_VBD clearly_RB
          demonstrated_VBN expression_NN of_IN both_DT plasmids_NNS ,_, indicating_VBG that_IN
          co-transfections_JJ are_VBP reliable_JJ using_VBG this_DT method_NN ._.
        
        
          PEI-mediated_NNP transfection_NN in_IN cultured_JJ human_JJ retinal_JJ
          ganglion_NN cells_NNS
          Cultures_NNP of_IN cells_NNS dissociated_JJ from_IN adult_NN human_JJ retina_NN
          were_VBD transfected_JJ with_IN plasmid_NN encoding_VBG EGFP_NNP after_IN 1_CD -_: 4_CD
          weeks_NNS 
          in_IN vitro_NN using_VBG the_DT same_JJ protocol_NN
          developed_VBN for_IN sympathetic_JJ neurons_NNS ._. A_DT variety_NN of_IN cells_NNS
          were_VBD transfected_JJ ,_, most_RBS notably_RB glia_NN (_( Figure_NN 8_CD A_DT )_) ._. Smaller_JJR ,_,
          process-bearing_JJ cells_NNS expressing_VBG EGFP_NNP were_VBD also_RB detected_VBN
          (_( Figures_NNS 8_CD Aand_NNP 8_CD B_NNP )_) ;_: these_DT cells_NNS possess_VBP a_DT morphology_NN that_WDT
          strongly_RB suggests_VBZ a_DT neuronal_NN origin_NN ._. Similar_JJ types_NNS of_IN
          cells_NNS were_VBD able_JJ to_TO express_VB the_DT β-gal_JJ plasmid_NN as_RB well_RB (_( not_RB
          shown_VBN )_) ._.
        
      
      
        Discussion_NNP
        Our_PRP$ data_NNS demonstrate_VBP the_DT utility_NN of_IN polyethyleneimine_NN as_IN
        a_DT vector_NN for_IN exogenous_JJ gene_NN delivery_NN in_IN cultured_JJ neurons_NNS ._.
        Although_IN the_DT sources_NNS of_IN the_DT neurons_NNS varied_VBD widely_RB in_IN age_NN
        and_CC species_NNS ,_, PEI_NNP was_VBD nonetheless_RB able_JJ to_TO facilitate_VB the_DT
        expression_NN of_IN at_IN least_JJS two_CD foreign_JJ genes_NNS ,_, LacZ_NNP and_CC EGFP_NNP ,_, in_IN
        each_DT of_IN the_DT experimental_JJ settings_NNS ._. This_DT finding_VBG underscores_VBZ
        the_DT versatility_NN of_IN PEI_NNP as_IN a_DT method_NN for_IN introducing_VBG genes_NNS
        into_IN postmitotic_JJ populations_NNS of_IN cells_NNS ,_, particularly_RB as_IN our_PRP$
        previous_JJ efforts_NNS to_TO transfect_NN sympathetic_JJ neurons_NNS using_VBG
        lipid-based_JJ reagents_NNS (_( Lipofectamine_NNP and_CC Lipofectin_NNP )_) had_VBD
        been_VBN unsuccessful_JJ ._.
        From_IN a_DT technical_JJ standpoint_NN ,_, PEI_NNP is_VBZ relatively_RB
        straightforward_JJ ,_, as_IN commercial_JJ preparations_NNS are_VBP sterile_JJ and_CC
        ready_JJ for_IN use_NN ._. There_EX are_VBP ,_, however_RB ,_, important_JJ factors_NNS to_TO
        consider_VB while_IN striving_VBG for_IN optimal_NN results_NNS ._. The_DT first_JJ is_VBZ
        maximizing_VBG yield_NN and_CC minimizing_VBG toxicity_NN ._. Although_IN the_DT
        reasons_NNS for_IN PEI_NNP toxicity_NN are_VBP not_RB completely_RB clear_JJ ,_, it_PRP
        appears_VBZ to_TO involve_VB the_DT disruption_NN of_IN the_DT endosome_NN /_NN lysosome_NN
        complex_JJ [_NN 4_CD ,_, 6_CD ]_NN ._. In_IN our_PRP$ experimental_JJ conditions_NNS ,_, the_DT
        optimal_NN density_NN for_IN transfection_NN of_IN rat_NN sympathetic_JJ neurons_NNS
        is_VBZ around_IN 30_CD neurons_NNS /_NN mm_NN 2_CD ,_, in_IN contrast_NN to_TO a_DT typical_JJ culture_NN
        density_NN of_IN 10_CD neurons_NNS /_NN mm_NN 2_CD [_NN 13_CD ]_NN ._. This_DT allows_VBZ for_IN sufficient_JJ
        numbers_NNS of_IN transfected_JJ cells_NNS and_CC appears_VBZ to_TO lessen_VB the_DT PEI_NNP
        burden_NN per_IN neuron_NN ,_, yet_RB does_VBZ not_RB preclude_VB detailed_JJ
        morphological_JJ analyses_NNS of_IN individual_JJ neurons_NNS ._. Another_DT
        factor_NN is_VBZ the_DT presence_NN of_IN serum_NN ._. Based_VBN on_IN our_PRP$ unpublished_JJ
        observations_NNS ,_, rat_NN sympathetic_JJ neurons_NNS that_WDT are_VBP transfected_JJ
        in_IN the_DT absence_NN of_IN serum_NN show_NN much_RB greater_JJR toxicity_NN than_IN
        those_DT in_IN which_WDT 2_CD ._. 5_CD %_NN serum_NN is_VBZ temporarily_RB added_VBN for_IN the_DT
        transfection_NN process_NN (_( data_NNS not_RB shown_VBN )_) ._. Furthermore_RB ,_, the_DT
        presence_NN of_IN serum_NN does_VBZ not_RB seem_VB to_TO greatly_RB interfere_VB with_IN
        the_DT transfection_NN process_NN of_IN either_DT rat_VB sympathetic_JJ or_CC human_JJ
        retinal_JJ neurons_NNS ,_, although_IN in_IN other_JJ cell_NN types_NNS it_PRP sometimes_RB
        does_VBZ [_NN 18_CD ,_, 19_CD ]_NN ._. Rinsing_NNP the_DT cultures_NNS immediately_RB after_IN
        centrifugation_NN is_VBZ also_RB a_DT critical_JJ step_NN in_IN mitigating_VBG the_DT
        toxic_JJ effects_NNS of_IN PEI_NNP ._. Increasing_VBG the_DT number_NN and_CC volume_NN of_IN
        rinses_NNS improves_VBZ cell_NN survival_NN ,_, but_CC decreases_VBZ the_DT yield_NN of_IN
        transfected_JJ cells_NNS (_( data_NNS not_RB shown_VBN )_) ._. Clearly_RB ,_, such_JJ
        parameters_NNS must_MD be_VB tailored_VBN to_TO the_DT specific_JJ type_NN of_IN cell_NN
        under_IN investigation_NN ._.
        Altering_NNP the_DT ratio_NN of_IN DNA_NNP to_TO PEI_NNP also_RB affects_VBZ the_DT yield_NN ._.
        In_IN our_PRP$ neuronal_NN cultures_NNS it_PRP appears_VBZ that_IN the_DT DNA_NNP :_: PEI_NNP ratio_NN
        of_IN 1_CD μg_NN :_: 5_CD μg_NN ,_, or_CC 0_CD ._. 2_CD ,_, which_WDT produces_VBZ complexes_NNS that_WDT bear_NN a_DT
        net_JJ positive_JJ charge_NN ,_, produces_VBZ the_DT highest_JJS yield_NN ._. This_DT is_VBZ in_IN
        contrast_NN to_TO previously_RB published_VBN data_NNS showing_VBG that_IN
        positively_RB charged_VBN complexes_NNS and_CC neutral_JJ complexes_NNS produce_VBP
        comparable_JJ yields_NNS in_IN lung_NN epithelial_NN cells_NNS [_NN 17_CD ]_NN ._. However_RB ,_,
        considering_VBG that_IN the_DT optimal_NN DNA_NNP :_: PEI_NNP ratio_NN may_MD vary_VB from_IN
        cell_NN line_NN to_TO cell_NN line_NN [_NN 19_CD ]_NN ,_, this_DT is_VBZ not_RB an_DT unexpected_JJ
        finding_NN ._.
        Perhaps_RB the_DT most_RBS attractive_JJ aspect_NN of_IN PEI-mediated_NNP gene_NN
        delivery_NN is_VBZ the_DT flexibility_NN of_IN the_DT method_NN ._. For_IN example_NN ,_, a_DT
        DNA_NNP /_NN PEI_NNP ratio_NN of_IN 0_CD ._. 4_CD also_RB produces_VBZ reasonable_JJ numbers_NNS of_IN
        transfected_JJ neurons_NNS in_IN our_PRP$ system_NN ,_, meaning_VBG that_IN the_DT
        measurement_NN of_IN the_DT DNA_NNP and_CC PEI_NNP solutions_NNS need_MD not_RB be_VB
        rigorously_RB accurate_JJ for_IN the_DT transfection_NN process_NN to_TO work_VB ._.
        The_DT applications_NNS can_MD vary_VB greatly_RB ,_, as_RB well_RB ._. PEI_NNP may_MD be_VB used_VBN
        in_IN conjunction_NN with_IN adenovirus_JJ vectors_NNS [_NN 2_CD ,_, 9_CD ,_, 11_CD ,_, 18_CD ,_, 19_CD ]_NN
        and_CC can_MD be_VB conjugated_JJ to_TO various_JJ ligands_NNS for_IN targeted_VBN gene_NN
        delivery_NN [_NN 10_CD ,_, 16_CD ]_NN or_CC to_TO minimize_VB nonspecific_JJ interactions_NNS
        with_IN blood_NN when_WRB injected_VBN into_IN the_DT circulatory_NN system_NN [_NN 20_CD ]_NN ._.
        It_PRP also_RB has_VBZ been_VBN shown_VBN to_TO be_VB effective_JJ as_IN a_DT vector_NN for_IN 
        in_IN vivo_NN transfection_NN in_IN the_DT mouse_NN
        brain_NN [_NN 21_CD ,_, 22_CD ]_NN and_CC lung_NN [_NN 17_CD ,_, 21_CD ]_NN ,_, as_RB well_RB as_IN a_DT potential_JJ
        way_NN to_TO target_VB therapeutic_JJ genes_NNS to_TO tumors_NNS [_NN 20_CD ]_NN ._.
        Our_PRP$ results_NNS confirm_VBP the_DT findings_NNS of_IN others_NNS that_WDT show_NN the_DT
        possibility_NN of_IN transfecting_VBG post-mitotic_JJ ,_, fully_RB
        differentiated_JJ cells_NNS using_VBG PEI_NNP [_NN 2_CD ,_, 23_CD ]_NN ._. In_IN addition_NN ,_, we_PRP
        show_VBP that_DT adult_NN human_JJ retinal_JJ neurons_NNS ,_, which_WDT have_VBP been_VBN
        fully_RB differentiated_JJ as_IN long_RB as_IN seven_CD decades_NNS ,_, are_VBP capable_JJ
        of_IN expressing_VBG foreign_JJ genes_NNS when_WRB administered_VBN in_IN this_DT
        manner_NN ._. As_IN the_DT eye_NN is_VBZ considered_VBN to_TO be_VB the_DT most_RBS accessible_JJ
        part_NN of_IN the_DT central_JJ nervous_JJ system_NN ,_, any_DT method_NN of_IN gene_NN
        transfer_NN that_WDT works_VBZ on_IN human_JJ retinal_JJ neurons_NNS 
        in_IN vitro_NN presents_VBZ an_DT attractive_JJ
        avenue_NN of_IN research_NN for_IN potential_JJ 
        in_IN vivo_NN applications_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Tissue_NNP Culture_NNP
          Sympathetic_NNP neuronal_NN cultures_NNS were_VBD obtained_VBN by_IN
          dissociating_VBG superior_JJ cervical_JJ ganglia_NN from_IN perinatal_NN (_( 21_CD
          day_NN embryos_NNS to_TO 1_CD day_NN postnatal_NN )_) Holtzman_NNP rats_NNS (_( Harlan_NNP
          Sprague-_NNP Dawley_NNP ,_, Indianapolis_NNP )_) ,_, using_VBG previously_RB described_VBD
          methods_NNS [_NN 13_CD ]_NN ._. Neurons_NNP were_VBD plated_JJ at_IN ∼_NN 30_CD cells_NNS /_NN mm_NN 2_CD onto_IN
          coverslips_NNS coated_VBN with_IN poly-_NN D-_NNP lysine_NN (_( 200_CD μg_NN /_NN ml_NN )_) ._.
          Cultures_NNP were_VBD maintained_VBN in_IN a_DT serum-free_JJ medium_NN [_NN 13_CD ]_NN
          containing_VBG β-nerve_JJ growth_NN factor_NN (_( β-_NN NGF_NNP ,_, 100_CD ng_NN /_NN ml_NN )_) ._. In_IN
          order_NN to_TO eliminate_VB nonneuronal_NN cells_NNS ,_, cultures_NNS were_VBD
          treated_VBN with_IN the_DT DNA_NNP synthesis_NN inhibitor_NN
          cytosine-β-_JJ D-_NNP arabinofuranoside_NN (_( 2_CD μM_NN )_) for_IN 48_CD h_NN beginning_VBG
          on_IN day_NN 2_CD ._.
          Adult_NNP human_JJ donor_NN eye_NN tissue_NN was_VBD obtained_VBN postmortem_NN
          from_IN Upstate_NNP New_NNP York_NNP Transplant_NNP Services_NNPS (_( Buffalo_NNP ,_, NY_NNP )_)
          with_IN approval_NN from_IN the_DT Health_NNP Sciences_NNPS Institutional_NNP
          Review_NNP Board_NNP ._. Familial_NNP consent_NN for_IN donation_NN and_CC research_NN
          was_VBD also_RB obtained_VBN ._. Tissue_NNP was_VBD rejected_VBN if_IN harvesting_NN did_VBD
          not_RB occur_VB within_IN 7_CD hours_NNS postmortem_NN and_CC 48_CD hours_NNS of_IN
          storage_NN on_IN ice_NN ,_, or_CC if_IN the_DT donor_NN had_VBD a_DT history_NN of_IN eye_NN
          disease_NN ._. Dissociated_NNP human_JJ retinal_JJ cultures_NNS were_VBD derived_VBN
          from_IN adult_NN donor_NN tissue_NN using_VBG a_DT protocol_NN adapted_VBN from_IN
          goldfish_NN retinal_JJ explant_NN studies_NNS [_NN 14_CD ]_NN ._. Retinal_NNP isolates_VBZ
          were_VBD diced_JJ into_IN 0_CD ._. 3_CD ×_NN 0_CD ._. 3_CD mm_NN pieces_NNS using_VBG a_DT tissue_NN
          chopper_NN (_( Brinkman_NNP Instruments_NNP ,_, Westbury_NNP ,_, NY_NNP )_) ,_, followed_VBN by_IN
          sequential_NN treatment_NN with_IN 0_CD ._. 1_CD %_NN hyaluronidase_NN /_NN 0_CD ._. 05_CD %_NN
          collagenase_NN and_CC 0_CD ._. 25_CD %_NN trypsin_NN (_( GIBCO_NNP ,_, Grand_NNP Island_NNP ,_, NY_NNP )_)
          in_IN Ca_MD 2_CD +_NN /_NN Mg_NNP 2_CD +_NN -_: free_JJ HBSS_NNP ._. After_IN several_JJ
          rinsing_VBG /_NN centrifugation_NN cycles_NNS ,_, a_DT flame-polished_JJ pipette_NN
          was_VBD used_VBN to_TO dissociate_VB the_DT cells_NNS ._. Cells_NNP were_VBD then_RB
          pelleted_JJ ,_, resuspended_JJ ,_, and_CC plated_JJ onto_IN 18_CD mm_NN glass_NN
          coverslips_NNS coated_VBN with_IN poly-_NN D-_NNP lysine_NN (_( 100_CD μg_NN /_NN ml_NN )_) and_CC
          laminin_NN (_( 10_CD μg_NN /_NN ml_NN )_) ._. Culture_NNP medium_NN consisted_VBD of_IN 1_CD :_: 1_CD
          DMEM_NNP /_NN F_NN 12_CD supplemented_JJ with_IN 10_CD %_NN FCS_NNP ,_, insulin_NN (_( 10_CD μg_NN /_NN ml_NN )_) ,_,
          transferrin_NN (_( 20_CD μg_NN /_NN ml_NN )_) ,_, 0_CD ._. 1_CD units_NNS /_NN ml_NN penicillin_NN ,_, and_CC 0_CD ._. 1_CD
          μg_NN /_NN ml_NN streptomycin_NN ._.
        
        
          Transfection_NNP
          Transfection_NNP took_VBD place_NN on_IN the_DT fifth_JJ day_NN 
          in_IN vitro_NN for_IN sympathetic_JJ neurons_NNS ,_,
          1_CD -_: 4_CD weeks_NNS 
          in_IN vitro_NN for_IN retinal_JJ cultures_NNS ._.
          Sympathetic_NNP neurons_NNS were_VBD treated_VBN with_IN 2_CD ._. 5_CD %_NN fetal_JJ calf_NN
          serum_NN immediately_RB prior_RB to_TO transfection_NN ._. The_DT total_JJ volume_NN
          of_IN media_NNS in_IN each_DT 20_CD mm_NN well_RB was_VBD ∼_NN 1_CD ml_NN ._. The_DT two_CD plasmids_NNS
          used_VBD encoded_JJ either_CC a_DT 1_CD ._. 6_CD Kb_NNP β-galactosidase_JJ gene_NN
          sequence_NN from_IN 
          E_NNP ._. coli_NNS or_CC the_DT enhanced_VBN green_JJ
          fluorescence_NN protein_NN (_( EGFP_NNP )_) gene_NN (_( Calbiochem_NNP ,_, Palo_NNP Alto_NNP )_) ,_,
          and_CC were_VBD purified_JJ by_IN the_DT CsCl_NNP method_NN ._. Various_JJ
          concentrations_NNS of_IN plasmid_NN and_CC PEI_NNP (_( ExGen_NNP 500_CD ,_, MBI_NNP
          Fermentas_NNP ,_, Hanover_NNP ,_, MD_NNP )_) were_VBD prepared_VBN ,_, using_VBG 150_CD mM_NN NaCl_NNP
          in_IN sterile_JJ water_NN as_IN the_DT diluent_NN ._. PEI_NNP and_CC plasmid_NN were_VBD
          mixed_JJ together_RB and_CC incubated_JJ for_IN 10_CD minutes_NNS at_IN room_NN
          temperature_NN to_TO allow_VB for_IN adequate_JJ binding_VBG of_IN the_DT plasmid_NN
          to_TO the_DT PEI_NNP ._. One_CD hundred_CD μl_NN of_IN plasmid_NN :_: PEI_NNP solution_NN was_VBD
          added_VBN to_TO each_DT 20_CD mm_NN well_RB and_CC the_DT 12_CD well_RB plate_NN was_VBD
          centrifuged_JJ at_IN 500_CD x_SYM 
          g_SYM for_IN 5_CD min_NN ._. After_IN centrifugation_NN ,_,
          the_DT cultures_NNS were_VBD washed_VBN once_RB with_IN 0_CD ._. 5_CD ml_NN DMEM_NNP ,_, treated_VBN
          with_IN 0_CD ._. 5_CD ml_NN serum-free_JJ media_NNS containing_VBG 0_CD ._. 1_CD units_NNS /_NN ml_NN
          penicillin_NN and_CC 0_CD ._. 1_CD μg_NN /_NN ml_NN streptomycin_NN ,_, and_CC returned_VBD to_TO
          the_DT incubator_NN ._.
        
        
          X-_NNP gal_NN staining_VBG
          Detection_NNP of_IN enzymatic_JJ activity_NN within_IN cells_NNS
          transfected_JJ with_IN the_DT β-galactosidase_JJ gene_NN was_VBD similar_JJ to_TO
          that_DT described_VBN by_IN Galileo_NNP et_CC al_NN ._. [_NN 15_CD ]_NN ._. Briefly_NNP ,_, cells_NNS
          were_VBD fixed_VBN for_IN 20_CD minutes_NNS in_IN 4_CD %_NN paraformaldehyde_NN ._. After_IN
          rinsing_VBG with_IN PBS_NNP ,_, cells_NNS were_VBD incubated_JJ in_IN the_DT dark_JJ (_( 20_CD h_NN
          at_IN 37_CD °_NN C_NNP )_) in_IN a_DT buffer_NN containing_VBG X-_NNP gal_NN substrate_NN (_( 1_CD
          mg_NN /_NN ml_NN )_) ,_, potassium_NN ferricyanide_NN (_( 100_CD mM_NN )_) ,_, and_CC potassium_NN
          ferrocyanide_NN (_( 100_CD mM_NN )_) ._. Coverslips_NNP were_VBD washed_VBN in_IN PBS_NNP and_CC
          mounted_VBD on_IN slides_NNS using_VBG an_DT elvanol-based_JJ medium_NN [_NN
          13_CD ]_NN ._.
        
        
          Immunocytochemistry_NNP
          Cultures_NNP were_VBD fixed_VBN in_IN 4_CD %_NN paraformaldehyde_NN for_IN 20_CD
          minutes_NNS ._. Cells_NNP were_VBD then_RB permeablilized_JJ in_IN 0_CD ._. 1_CD %_NN Triton_NNP in_IN
          PBS_NNP for_IN 3_CD minutes_NNS and_CC blocked_VBN in_IN a_DT 10_CD %_NN goat_NN serum_NN ,_, 5_CD %_NN
          bovine_JJ serum_NN solution_NN for_IN 20_CD minutes_NNS ._. Mouse_NNP monoclonal_NN Ab_NNP
          5_CD B_NNP 88_CD to_TO β-galactosidase_JJ (_( GIBCO_NNP )_) was_VBD used_VBN at_IN a_DT
          concentration_NN of_IN 2_CD ._. 5_CD g_SYM /_NN ml_NN ,_, followed_VBN by_IN
          rhodamine-conjugated_JJ ,_, affinity-purified_JJ goat_NN anti-mouse_JJ
          IgG_NNP antibody_NN (_( Boehringer_NNP Mannheim_NNP ,_, Indianapolis_NNP ,_, IN_IN )_) ._.
          Mouse_NNP monoclonal_NN Ab_NNP SMI_NNP 52_CD to_TO microtubule-associated_JJ
          protein_NN 2_CD (_( Sternberger_NNP Monoclonals_NNP ,_, Baltimore_NNP ,_, MD_NNP )_) was_VBD
          used_VBN at_IN a_DT concentration_NN of_IN 2_CD μg_NN /_NN ml_NN ,_, followed_VBN by_IN the_DT
          rhodamine_NN goat_NN anti-mouse_JJ secondary_JJ ._.
        
      
    
  
